The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Depression and Anxiety in Patients With Cancer: A Cross-Sectional Study
Open accessAbstract
Objectives: Depression and anxiety persist in cancer patients, creating an additional burden during treatment and making it more challenging in terms of management and control. Studies on the prevalence of depression and anxiety among cancer patients in the Middle East are limited and include many limitations such as their small sample sizes and restriction to a specific type of cancer in specific clinical settings. This study aimed to describe the prevalence and risk factors of depression and anxiety among cancer patients in the inpatient and outpatient settings. Materials and Methods: A total of 1,011 patients (399 inpatients and 612 outpatients) formed the study sample. Patients’ psychological status was assessed using the Hospital Anxiety and Depression Scale (HADS), the Patient Health Questionnaire (PHQ-9), and the Generalized Anxiety Disorder 7-item (GAD-7) scale. The prevalence rate of depressive and anxious symptomatology was estimated by dividing the number of patients who exceeded the borderline score: 10 or more for each subscale of the HADS scale, 15 or more for the GAD-7 scale, and 15 or more in the PHQ-9 by the total number of the patients. Risk factors were identified using logistic regression. Results: The prevalence of depressive and anxious symptomatology among all patients was 23.4% and 19.1–19.9%, respectively. Depressive symptomatology was more prevalent across patients who were hospitalized (37.1%) compared with patients in the outpatient setting (14.5%) (p < 0.001). Similarly, anxious symptomatology was more prevalent in the inpatient setting (p < 0.001). In the inpatient setting, depressive symptomatology was more prevalent among patients with bladder cancer, while severe anxious symptomatology was more prevalent across patients with lung cancer. In the outpatient setting, depressive and anxious symptomatology was more prevalent among breast and prostate cancer patients, respectively. Despite that, around 42.7% and 24.8% of the patients, respectively, reported that they feel anxious and depressed, and only 15.5% of them were using medications to manage their conditions. Conclusion: Our study findings demonstrated a higher prevalence of depressive and anxious symptomatology in the inpatient setting and advanced disease stages. In addition, the underutilization of antidepressant therapy was observed. There is a need to consider mental disorders as part of the treatment protocol for cancer patients. Enhanced clinical monitoring and treatment of depression and anxiety of cancer patients are required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779
Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70002-x · Cited by 2,449
EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER
Spiegel, D., Kraemer, H., Bloom, J., & Gottheil, E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91551-1 · Cited by 2,353
Sample Size Determination in Health Studies: A Practical Manual.
Lachenbruch, P. A., Lwanga, S. K., & Lemeshow, S. (1991) · Journal of the American Statistical Association · doi:10.2307/2290547 · Cited by 2,097
Levis, B., Benedetti, A., & Thombs, B. D. (2019) · BMJ · doi:10.1136/bmj.l1476 · Cited by 1,718
Prevalence of depression in patients with cancer
Massie, M. J. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh014 · Cited by 1,408 · cited 1×
“Previous studies have reported that the prevalence of depressive disorders among cancer patients is two to three times higher than those of the general population (Massie, 2004; Pirl, 2004).”
BackgroundPrevalence and incidence studies of anxiety disorders: A systematic review of the literature
Somers, J. M., Goldner, E. M., Waraich, P., & Hsu, L. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100206 · Cited by 1,114
Krebber, A. M. H., Buffart, L. M., Kleijn, G., Riepma, I. C., de Bree, R., Leemans, C. R., Becker, A., Brug, J., van Straten, A., Cuijpers, P., et al. (2014) · Psycho-Oncology · doi:10.1002/pon.3409 · Cited by 908
Depression and anxiety in patients with cancer
Pitman, A., Suleman, S., Hyde, N., & Hodgkiss, A. (2018) · BMJ · doi:10.1136/bmj.k1415 · Cited by 871
Niedzwiedz, C. L., Knifton, L., Robb, K. A., Katikireddi, S. V., & Smith, D. J. (2019) · BMC Cancer · doi:10.1186/s12885-019-6181-4 · Cited by 756
Prevalence and Incidence Studies of Mood Disorders: A Systematic Review of the Literature
Waraich, P., Goldner, E. M., Somers, J. M., & Hsu, L. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900208 · Cited by 522
Depression in cancer patients: Pathogenesis, implications and treatment (Review)
SMITH, H. R. (2015) · Oncology Letters · doi:10.3892/ol.2015.2944 · Cited by 478
Sawaya, H., Atoui, M., Hamadeh, A., Zeinoun, P., & Nahas, Z. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.03.030 · Cited by 450
Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Ramessur, R., Murray, G., & Sharpe, M. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70313-x · Cited by 435
Prevalence of depression in adults with cancer: a systematic review
Walker, J., Holm Hansen, C., Martin, P., Sawhney, A., Thekkumpurath, P., Beale, C., Symeonides, S., Wall, L., Murray, G., & Sharpe, M. (2013) · Annals of Oncology · doi:10.1093/annonc/mds575 · Cited by 308
Spiegel, D., Butler, L. D., Giese‐Davis, J., Koopman, C., Miller, E., DiMiceli, S., Classen, C. C., Fobair, P., Carlson, R. W., & Kraemer, H. C. (2007) · Cancer · doi:10.1002/cncr.22890 · Cited by 290 · cited 1×
“…it more challenging in terms of its management and control (Walker et al., 2013; Ahmed, 2019), compliance during the treatment course (Ahmed, 2019), duration of hospital stay (Koenig et al., 1992; McDermott et al., 2018), and, ultimately, survival rate (Spiegel et al., 1989; Spiegel and Li, 2007).”
BackgroundDevelopment and validation of Arabic version of the Hospital Anxiety and Depression Scale
Terkawi, A., Tsang, S., AlKahtani, G., Al-Mousa, S., Al Musaed, S., AlZoraigi, U., Alasfar, E., Doais, K., Abdulrahman, A., & Altirkawi, K. (2017) · Saudi Journal of Anaesthesia · doi:10.4103/sja.sja_43_17 · Cited by 288
Assessment of depression severity with the PHQ-9 in cancer patients and in the general population
Hinz, A., Mehnert, A., Kocalevent, R.-D., Brähler, E., Forkmann, T., Singer, S., & Schulte, T. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0728-6 · Cited by 272
Chochinov, H. M. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00456-9 · Cited by 271 · cited 2×
“Patient vulnerability exacerbates the ability to become depressed and anxious, which is reported to be caused by some socioeconomic factors and disease stages (Chochinov, 2001; Smith, 2015).”
BackgroundDelgado-Guay, M., Parsons, H. A., Li, Z., Palmer, J. L., & Bruera, E. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0529-7 · Cited by 259
Evidence Report on the Occurrence, Assessment, and Treatment of Depression in Cancer Patients
Pirl, W. F. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh026 · Cited by 257
Lengacher, C. A., Reich, R. R., Paterson, C. L., Ramesar, S., Park, J. Y., Alinat, C., Johnson-Mallard, V., Moscoso, M., Budhrani-Shani, P., Miladinovic, B., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.7874 · Cited by 255
Evidence‐based treatment of depression in patients with cancer
Li, M., Fitzgerald, P., & Rodin, G. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7372 · Cited by 236
Caruso, R., Nanni, M. G., Riba, M., Sabato, S., Mitchell, A. J., Croce, E., & Grassi, L. (2017) · Acta Oncologica · doi:10.1080/0284186x.2016.1266090 · Cited by 203
van den Berg, S. W., Gielissen, M. F. M., Custers, J. A. E., van der Graaf, W. T. A., Ottevanger, P. B., & Prins, J. B. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.9386 · Cited by 201 · cited 1×
“…received the required treatment (Waraich et al., 2004; Brothers et al., 2011; Findley et al., 2012; Li et al., 2012; Baltenberger et al., 2014; Nakash et al., 2014; Jassim et al., 2015; van den Berg et al., 2015; Kanera et al., 2016; Lengacher et al., 2016; Reich et al., 2017; Ahmed, 2019).”
BackgroundKissane, D., & Li, Y. (2008) · Cancer · doi:10.1002/cncr.23179 · Cited by 197
Reich, R. R., Lengacher, C. A., Alinat, C. B., Kip, K. E., Paterson, C., Ramesar, S., Han, H. S., Ismail-Khan, R., Johnson-Mallard, V., Moscoso, M., et al. (2017) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2016.08.005 · Cited by 197
Esser, P., Hartung, T. J., Friedrich, M., Johansen, C., Wittchen, H., Faller, H., Koch, U., Härter, M., Keller, M., Schulz, H., et al. (2018) · Psycho-Oncology · doi:10.1002/pon.4681 · Cited by 185
Hartung, T. J., Friedrich, M., Johansen, C., Wïttchen, H., Faller, H., Koch, U., Brähler, E., Härter, M. C., Keller, M., Schulz, H., et al. (2017) · Cancer · doi:10.1002/cncr.30846 · Cited by 173
Psychological distress in cancer patients with advanced disease
Kaasa, S., Malt, U., Hagen, S., Wist, E., Moum, T., & Kvikstad, A. (1993) · Radiotherapy and Oncology · doi:10.1016/0167-8140(93)90073-h · Cited by 165
Psychological interventions for women with non-metastatic breast cancer
Jassim, G. A., Whitford, D. L., Hickey, A., & Carter, B. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008729.pub2 · Cited by 163
Abdel-Razeq, H., Attiga, F., & Mansour, A. (2015) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2015.02.001 · Cited by 159
Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer
Vodermaier, A., Linden, W., MacKenzie, R., Greig, D., & Marshall, C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.503 · Cited by 149
Nakash, O., Levav, I., Aguilar-Gaxiola, S., Alonso, J., Andrade, L. H., Angermeyer, M. C., Bruffaerts, R., Caldas-de-Almeida, J. M., Florescu, S., de Girolamo, G., et al. (2014) · Psycho-Oncology · doi:10.1002/pon.3372 · Cited by 117
Chemotherapy-induced nausea and vomiting: optimizing prevention and management.
Rao, K. V., & Faso, A. (2012) · PubMed Central · Cited by 100
A Brief Depression Scale for Use in the Medically Ill
Koenig, H. G., Cohen, H. J., Blazer, D. G., Meador, K. G., & Westlund, R. E. (1992) · The International Journal of Psychiatry in Medicine · doi:10.2190/m1f5-f40p-c4kd-ypa3 · Cited by 99
Nead, K. T., Sinha, S., Yang, D. D., & Nguyen, P. L. (2017) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.07.016 · Cited by 96
Remme, M., Narasimhan, M., Wilson, D. P., Ali, M., Vijayasingham, L., Ghani, F., & Allotey, P. A. (2019) · BMJ · doi:10.1136/bmj.l1228 · Cited by 83
Härter, M. C., Woll, S., Wunsch, A., Bengel, J., & Reuter, K. (2005) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-005-0992-0 · Cited by 76
Brothers, B. M., Yang, H., Strunk, D. R., & Andersen, B. L. (2011) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0022566 · Cited by 70
Steroid-induced mental disorders in cancer patients: a systematic review
Ismail, M. F., Lavelle, C., & Cassidy, E. (2017) · Future Oncology · doi:10.2217/fon-2017-0306 · Cited by 62
Kanera, I. M., Willems, R. A., Bolman, C. A. W., Mesters, I., Zambon, V., Gijsen, B. C., & Lechner, L. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.5975 · Cited by 59
McDermott, C. L., Bansal, A., Ramsey, S. D., Lyman, G. H., & Sullivan, S. D. (2018) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2018.08.004 · Cited by 42
Depression in patients with colorectal cancer in Saudi Arabia
Ahwal, M. S. A., Zaben, F. A. A., Khalifa, D. A., Sehlo, M., Ahmad, R., & Koenig, H. G. (2015) · Psycho-Oncology · doi:10.1002/pon.3706 · Cited by 32
Gharaei, H. A., Dianatinasab, M., kouhestani, M., Fararouei, M., Moameri, H., Pakzad, R., & Ghaiasvand, R. (2019) · Epidemiology and Health · doi:10.4178/epih.e2019030 · Cited by 32
Depression Treatment Patterns among Elderly with Cancer
Findley, P. A., Shen, C., & Sambamoorthi, U. (2012) · Depression Research and Treatment · doi:10.1155/2012/676784 · Cited by 29
Depression and religiosity and their correlates in Lebanese breast cancer patients
Kassm, S. A., Hlais, S., Khater, C., Chehade, I., Haddad, R. S., Chahine, J., Yazbeck, M., Warde, R. A., & Naja, W. (2017) · Psycho-Oncology · doi:10.1002/pon.4386 · Cited by 22
Fischer, F. H., Levis, B., Falk, C. F., Sun, Y., Ioannidis, J. P. A., Cuijpers, P. J., Shrier, I., Benedetti, A., & Thombs, B. D. (2021) · Psychological Medicine · doi:10.1017/s0033291721000131 · Cited by 21
Treatment of depressive symptoms in patients with cancer
Baltenberger, E. P., Schmitt, G., & Thomas, C. J. (2014) · Mental Health Clinician · doi:10.9740/mhc.n194575 · Cited by 8
Cited by
Getie, A., Ayalneh, M., & Bimerew, M. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06599-5 · Cited by 117
Cumulative burden of psychiatric disorders and self-harm across 26 adult cancers
Chang, W. H., & Lai, A. G. (2022) · Nature Medicine · doi:10.1038/s41591-022-01740-3 · Cited by 81
Zari Moin, Z., Abolmaali Alhosseini, K., & Sirafi, M. R. (2022) · Archives of Breast Cancer · doi:10.32768/abc.202294497-504 · Cited by 3
“Anxiety is prevalent in cancer patients.(4,5) Specifically, anxiety may begin automatically because of the positive thoughts about its benefit and persist due to the efforts made to stop it as it is created by a bad experience and Original Article Open Access”
BackgroundGarcía-Torres, F., García-Carmona, M., Moreno, E., Jurado-González, F., & Aguilera-Martín, Á. (2024) · SAGE Open · doi:10.1177/21582440241297591 · Cited by 1
“…frequently as a consequence of the illness and the subsequent treatments, negatively influencing key aspects of cancer care and survival (Bach et al., 2021; Naser et al., 2021; Polan´ski et al., 2017; Schieber et al., 2019; Shrestha et al., 2019; Wu et al., 2022; Zamani & Alizadeh-Tabari, 2023).”
Rosario-Ramos, L. P., Quiles-Bengochea, C., Laporte-Estela, G., Rivera, N., Graulau-Burgos, A. M., Peña-Vargas, C., Hernández-Torres, R., Cortes-Castro, C., Rodriguez-Castro, Z., Castro-Figueroa, E. M., et al. (2026) · Healthcare · doi:10.3390/healthcare14162471
Metadata
- Authors
- Naser, A. Y., Hameed, A. N., Mustafa, N., Alwafi, H., Dahmash, E. Z., Alyami, H. S., & Khalil, H.
- Venue
- Frontiers in Psychology
- Publisher
- Frontiers Media SA
- Published
- 2021-04-15
- Volume
- 12
- Pages
- 585534-585534
- ISSN
- 1664-1078 (ISSN-L)
- OpenAlex
- W3154330664
- Cited by
- 281
- References
- 53
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.